Feed Preview

Fast Growing

Risk for Schizophrenia

Risk for Schizophrenia  diagram by Yamada et al, PLOS One
Yamada et al, PLOS One

Schizophrenia is a complex disease and emerging studies have identified hundreds of genetic loci harbouring schizophrenia-associated variants. These variants can potentially increase the risk for developing Schizophrenia. Discover the latest research on Risk For Schizophrenia here.

Top 20 most recent papers
Annals of Neurology

Fine-mapping of SNCA in REM sleep behavior disorder and overt synucleinopathies

Annals of NeurologyJanuary 25, 2020
Lynne KrohnZiv Gan-Or
bioRxiv

Genes influenced by MEF2C contribute to neurodevelopmental disease via gene expression changes that affect multiple types of cortical excitatory neurons

bioRxivDecember 16, 2019
Donna CosgroveDerek W Morris
6
bioRxiv

Rare protein coding variants implicate genes involved in risk of suicide death

bioRxivJanuary 11, 2020
Emily DiBlasiHilary Coon
7
Schizophrenia Bulletin

Cognitive Brain Signatures of Youth With Early Onset and Relatives With Schizophrenia: Evidence From fMRI Meta-analyses

Schizophrenia BulletinJanuary 25, 2020
Marie ArsalidouVadim Ushakov
NPJ Parkinson's Disease

Hypomania and saccadic changes in Parkinson's disease: influence of D2 and D3 dopaminergic signalling

NPJ Parkinson's DiseaseJanuary 24, 2020
Esther A PelzerLars Timmermann
The International Journal of Neuropsychopharmacology

Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives and Healthy Subjects

The International Journal of NeuropsychopharmacologyJanuary 5, 2020
Kazutaka OhiKazutaka Ikeda
2
Scientific Reports

Pharmacological enrichment of polygenic risk for precision medicine in complex disorders

Scientific ReportsJanuary 23, 2020
William R ReayMurray J Cairns
31
BMJ Open

Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence

BMJ OpenJanuary 22, 2020
Irene BighelliStefan Leucht
Frontiers in Psychiatry

Altered Expression of a Unique Set of Genes Reveals Complex Etiology of Schizophrenia

Frontiers in PsychiatryJanuary 11, 2020
Ashutosh KumarPavan Kumar
7
1
Frontiers in Behavioral Neuroscience

A Cross-Species Systems Genetics Analysis Links APBB1IP as a Candidate for Schizophrenia and Prepulse Inhibition

Frontiers in Behavioral NeuroscienceJanuary 11, 2020
David G AshbrookReinmar Hager
7
Schizophrenia Bulletin

Assessing the Causal Effects of Human Serum Metabolites on 5 Major Psychiatric Disorders

Schizophrenia BulletinJanuary 11, 2020
Jian YangXiancang Ma
11
Cells

Novel Approaches for Identifying the Molecular Background of Schizophrenia

CellsJanuary 23, 2020
Arkadiy K GolovAnd Vera E Golimbet
2
Vertex : revista argentina de psiquiatriá

Treatment adherence and effectiveness of extended-release antipsychotics in a hospital setting

Vertex : revista argentina de psiquiatriáJanuary 23, 2020
Kazuhiro Tajima-PozoFrancisco Montañes-Rada
Biological Psychiatry

A Pattern of Cognitive Deficits Stratified for Genetic and Environmental Risk Reliably Classifies Patients With Schizophrenia From Healthy Control Subjects

Biological PsychiatryJanuary 18, 2020
Linda A AntonucciAlessandro Bertolino
4
1
Schizophrenia Research

Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort

Schizophrenia ResearchDecember 31, 2019
Jerome H TaylorRaquel E Gur
1
Genetic Epidemiology

Robust kernel association testing (RobKAT)

Genetic EpidemiologyJanuary 17, 2020
Kara MartinezJung-Ying Tzeng
1
Cells

CD38, CD157, and RAGE as Molecular Determinants for Social Behavior

CellsDecember 29, 2019
Haruhiro HigashidaOlga Lopatina
7
Neuroscience Letters

Genetic variants associated with psychotic symptoms across psychiatric disorders

Neuroscience LettersJanuary 17, 2020
Marco CalabròAlessandro Serretti
The Australian and New Zealand Journal of Psychiatry

Reduced activation of the ventromedial prefrontal cortex during self-referential processing in individuals at ultra-high risk for psychosis

The Australian and New Zealand Journal of PsychiatryJanuary 21, 2020
Hye Yoon ParkSuk Kyoon An
1
JAMA Psychiatry

Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders: A Genome-wide Association Study

JAMA PsychiatryJanuary 9, 2020
Shahram BahramiOle A Andreassen
59
5
2

See more papers from this feed

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Catatonia

Catatonia is a psychomotor syndrome with motor and behavioral symptoms, and can occur in both patients with or without psychiatric illness. Discover the latest research on Catatonia here.

Catatonic Schizophrenia

Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.

Comorbidity In Psychiatry

There is ongoing debate regarding the handling of comorbidity in psychiatric disorders, and determining whether the issue lies with the categorizations of diagnostic conventions or if there is an underlying pathology that links multiple diseases. Understanding how to give the proper diagnosis/diagnoses would allow for optimal management of the patient. Find the latest research on comorbidity in psychiatry here.

Epigenetics & Psychiatry

Psychiatric disorders are known to be multifaceted in their pathophysiology. Because epigenetic changes can be sensitive to the environment, inherited, and reversible, the study of epigenetics in psychiatric disease is a logical way to understand the natural history of the disease as well as to develop therapeutics. Find the latest research on epigenetics and psychiatry here.

Forensic Psychiatry

Forensic psychiatry includes the relationship between psychiatric abnormalities and legal violations and crimes. Discover the latest research on forensic psychiatry here.

Inflammation and Immunity in Schizophrenia

Schizophrenia is a complex mental disease caused by a combination of serial alterations in genetic and environmental factors, including inflammation and immunity. Here is the latest research.

Neuropsychiatry

Neuropsychiatry is an emerging field at the intersection of neurology and psychiatry, driven by the unprecedented advances in neuroscience. Here are the latest discoveries in neuropsychiatry.


Paranoid Disorders

Paranoid disorders are psychiatric disorders with the suspicion and belief that others are plotting against them, leading to mistrust of others. These symptoms of paranoia can be seen in other psychiatric disorders including dementia and schizophrenia. Here is the latest research on paranoid disorders.

© 2020 Meta ULC. All rights reserved
/feed-previews/risk-for-schizophrenia/2d86e375-3384-4b00-83f1-0efe10d45449